Publication not explained
Read the Original
This page is a summary of: A small molecule based on the pRb2/p130 spacer domain leads to inhibition of cdk2 activity, cell cycle arrest and tumor growth reduction in vivo, Oncogene, October 2006, Springer Science + Business Media, DOI: 10.1038/sj.onc.1209987.
You can read the full text:
The following have contributed to this page